Figure 3.
Detailed schematic of therapy changes in oral nonbiologic DMARD patients and in MTX. aThis refers to oral nonbiologic DMARD users. bMTX users are a subgroup of the oral nonbiologic DMARD users. cThese categories presented are not mutually exclusive. dThese categories presented are not mutually exclusive. eThese categories presented are not mutually exclusive. DMARD, disease-modifying antirheumatic drug; MTX, methotrexate.